Oncopeptides AB (publ) (ONCO.ST)

SEK 1.54

(1.18%)

Annual Balance Sheets

(In SEK)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 238.37 Million 385.32 Million 439.37 Million 946.75 Million 993.48 Million 444.53 Million
Total Current Assets 202.9 Million 364.03 Million 412.37 Million 894.79 Million 970.88 Million 441.31 Million
Cash And Short Term Investments 173.4 Million 344.51 Million 362.18 Million 840.25 Million 926.18 Million 375.61 Million
Cash and Cash Equivalents 173.4 Million 344.51 Million 362.18 Million 840.25 Million 926.18 Million 375.61 Million
Short Term Investments 32 Thousand 348 Thousand 2.11 Million 12.22 Million - -850 Thousand
Net Receivables 27.06 Million 17.26 Million 37.99 Million 23.22 Million 6.97 Million 2.45 Million
Inventory 2.42 Million - 1.00 8.66 Million - -2.45 Million
Other Current Assets - 2.25 Million -1000.00 22.65 Million 37.72 Million 65.69 Million
Total Non-Current Assets 35.47 Million 21.28 Million 27 Million 51.95 Million 22.6 Million 3.21 Million
Net PPE 34.62 Million 20.43 Million 24.74 Million 38.33 Million 17.19 Million 2.36 Million
Good Will And Intangible Assets - - 1.4 Million 1.83 Million 2.11 Million -
Good Will - - - - - -
Intangible Assets - - 1.4 Million 1.83 Million 2.11 Million -
Long-Term Investments 852 Thousand 851 Thousand 851 Thousand 3.62 Million 1.03 Million 851 Thousand
Tax Assets - - -851 Thousand 8.17 Million 2.26 Million -
Other Non Current Assets -1.00 - -26.15 Million - 1.00 -
Other Assets 1.00 - - - - -
Total Liabilities 181.59 Million 91.03 Million 228.5 Million 369.85 Million 196.47 Million 128.69 Million
Total Current Liabilities 44.93 Million 85.67 Million 225.28 Million 354.4 Million 165.18 Million 113.84 Million
Account Payables 15.02 Million 28.21 Million 35.7 Million 136.13 Million 80.98 Million 25.27 Million
Tax Payables 579 Thousand 6.77 Million 7.02 Million 14.24 Million 5.47 Million 4.05 Million
Short Term Debt 5.13 Million 5.99 Million 10.98 Million 12.42 Million 6.65 Million -
Deferred Revenue 500 Thousand - 128.68 Million 197.46 Million 77.35 Million -
Other Current Liabilities 24.27 Million 51.45 Million 49.91 Million 8.37 Million 189 Thousand 88.57 Million
Total Non Current Liabilities 136.66 Million 5.35 Million 3.21 Million 15.45 Million 31.29 Million 14.85 Million
Long-Term Debt 106.48 Million 3.54 Million 3.2 Million 6.92 Million 8.24 Million -
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 30.17 Million 1.81 Million 13 Thousand 8.53 Million 23.05 Million 14.85 Million
Other Liabilities - - - - - -
Total Equity 56.78 Million 294.29 Million 210.86 Million 576.89 Million 797.01 Million 315.83 Million
Stock Holders Equity 56.78 Million 294.29 Million 210.86 Million 576.89 Million 797.01 Million 315.83 Million
Common Stock 10.51 Million 10.47 Million 8.36 Million 7.54 Million 6.15 Million 4.89 Million
Retained Earnings -5.36 Billion -5.11 Billion -4.77 Billion -3.34 Billion -1.75 Billion -961.91 Million
Accumulated other comprehensive income 46.26 Million -2.29 Million -918 Thousand -1.54 Million 2000.00 22 Thousand
Common Stock Equity 56.78 Million 294.29 Million 210.86 Million 576.89 Million 797.01 Million 315.83 Million
Capital Lease Obligation 19.66 Million 9.54 Million 14.19 Million 19.35 Million 6.65 Million -
Total Investments 32 Thousand 851 Thousand 50 Thousand 3.62 Million 1.03 Million 1000.00
Total Debt 106.48 Million 9.54 Million 14.19 Million 19.35 Million 6.65 Million -
Net Debt -66.92 Million -334.97 Million -347.99 Million -820.9 Million -919.53 Million -375.61 Million

Balance Sheet Charts